ProfileGDS4718 / 1555775_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 30% 26% 20% 29% 26% 26% 28% 26% 32% 26% 33% 30% 36% 28% 24% 23% 26% 31% 28% 27% 28% 28% 23% 30% 28% 30% 18% 23% 29% 29% 30% 28% 24% 27% 28% 26% 27% 23% 25% 21% 29% 29% 22% 26% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.555530
GSM549102patient 115, normal, homogenized [OPG study]4.4092726
GSM549104patient 119, normal, homogenized [OPG study]4.1389920
GSM549108patient 138, normal, homogenized [OPG study]4.5286729
GSM549119patient 077, normal, homogenized [OPG study]4.3769826
GSM549133patient 032, cancer, homogenized [OPG study]4.3317526
GSM549139patient 042, cancer, homogenized [OPG study]4.4212828
GSM549099patient 107, normal, homogenized [OPG study]4.4015226
GSM549109patient 139, normal, homogenized [OPG study]4.6446932
GSM549110patient 046, normal, homogenized [OPG study]4.3966926
GSM549114patient 063, normal, homogenized [OPG study]4.6053433
GSM549122patient 082, normal, homogenized [OPG study]4.5433730
GSM549134patient 033, cancer, homogenized [OPG study]4.8066436
GSM549136patient 036, cancer, homogenized [OPG study]4.4165328
GSM549140patient 044, cancer, homogenized [OPG study]4.2711724
GSM549111patient 047, normal, homogenized [OPG study]4.2216823
GSM549113patient 057, normal, homogenized [OPG study]4.3335426
GSM549132patient 031, cancer, homogenized [OPG study]4.5528331
GSM549137patient 038, cancer, homogenized [OPG study]4.4484928
GSM549142patient 047, cancer, homogenized [OPG study]4.5072527
GSM549100patient 110, normal, homogenized [OPG study]4.4617728
GSM549107patient 135, normal, homogenized [OPG study]4.4308428
GSM549115patient 068, normal, homogenized [OPG study]4.1900923
GSM549116patient 072, normal, homogenized [OPG study]4.5035530
GSM549120patient 078, normal, homogenized [OPG study]4.4631128
GSM549131patient 030, cancer, homogenized [OPG study]4.4985430
GSM549118patient 074, normal, homogenized [OPG study]4.0904318
GSM549129patient 027, cancer, homogenized [OPG study]4.2592623
GSM549123patient 088, normal, homogenized [OPG study]4.490929
GSM549124patient 006, cancer, homogenized [OPG study]4.5367129
GSM549126patient 015, cancer, homogenized [OPG study]4.5421130
GSM549128patient 025, cancer, homogenized [OPG study]4.4386228
GSM549103patient 117, normal, homogenized [OPG study]4.3416924
GSM549117patient 073, normal, homogenized [OPG study]4.3970627
GSM549138patient 041, cancer, homogenized [OPG study]4.421828
GSM549141patient 045, cancer, homogenized [OPG study]4.3017726
GSM549130patient 028, cancer, homogenized [OPG study]4.4243927
GSM549101patient 111, normal, homogenized [OPG study]4.2933823
GSM549105patient 128, normal, homogenized [OPG study]4.3631825
GSM549106patient 134, normal, homogenized [OPG study]4.1450821
GSM549112patient 048, normal, homogenized [OPG study]4.4738529
GSM549125patient 011, cancer, homogenized [OPG study]4.5050929
GSM549127patient 024, cancer, homogenized [OPG study]4.1928922
GSM549135patient 035, cancer, homogenized [OPG study]4.3348926